Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (557)

  • Gutierrez, A; Zeberio, I; Penalver, FJ; Martinez-Barranco, P; Perez, S; Morillo, D; Martin, X; Nicolas, C; Ferrero, A; Jimenez-Ubieto, A; Bastos-Oreiro, M; Davila-Valls, J; Calle, MV; Perez, M; Rodriguez, G; Alonso, A; Garcia-Noblejas, A; Argüello, DS; Knight, T; Fernandez, A; Lopez, J; Oteyza, JPD; Villambrosia, SGD; Perez, E; Marin, A; Navarro, MB; Fernandez, R; Gomez, P; Hueso, JA; Ponce, MJP; Bravo, P; Garcia-Belmonte, D; De La Nuez, H; Nistal, S; Abrisqueta, P; Iban, F; Palomera, L; Donato, E; Provencio, A; Infante, MS; Gonzalez-Barca, E.

    Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO

    Blood Advances. 2025; 9(19): 4924-4935 [doi:10.1182/bloodadvances.2025016661]

  • Encinas, C; Blanchard, MJ; Fernández, RA; Hernández-Rivas, JA; Tamayo, RR; Machado-Vílchez, M; Martínez-López, J; Mateos, MV.

    Factors Increasing the Risk of Infection in Patients With Multiple Myeloma: From Biology to Prevention

    Clinical Lymphoma Myeloma & Leukemia. 2025; 25(10): [doi:10.1016/j.clml.2025.06.012]

  • Puga, B; Bass, F; Molina, J; Benavente, R; Andrade, A; Majlis, A; Cabrera, ME; Kwon, M.

    Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in the public Chilean national health system: A single center study

    HEMATOLOGY TRANSFUSION AND CELL THERAPY. 2025; 47(4): [doi:10.1016/j.htct.2025.103982]

  • Palmerini, E; Meazza, C; Tamburini, A; Márquez-Vega, C; Bisogno, G; Fagioli, F; Ferraresi, V; Milano, GM; Coccoli, L; Rubio-San-Simón, A; Gallego, O; Riestra, MEL; Manzitti, C; Mora, J; Vaz-Salgado, MA; Luksch, R; Mata, C; Pierini, M; Carretta, E; Cesari, M; Paioli, A; Marrari, A; Scotlandi, K; Serra, M; Asaftei, SD; Gambarotti, M; Picci, P; Ferrari, S; Valverde, C; Ibrahim, T; Broto, JM.

    Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials

    JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(28): Nº de citas: 1 [doi:10.1200/JCO-25-00210]

  • Fidalgo, AP; Alonso, P; Andión, M; Cañete, A; Collado, E; Colino, CG; Codina, JG; Carrasco, XD; Sanz, RG; Expósito, SH; Lopez-Fernandez, T; Medin, G; Molinés, A; Vega, AM; Ramos, M; Miguel, IS; García, JS; Santolaya, F.

    Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain

    CLINICAL & TRANSLATIONAL ONCOLOGY. 2025; : [doi:10.1007/s12094-025-04047-0]

  • Foran, JM; Sanz, GF; Watts, JM; Brunner, AM; Fossard, G; Della Porta, MG; Tsai, XCH; Garcia-Manero, G; Dimicoli-Salazar, S; Fletcher, L; Kim, YJ; Font, P; Alfonso-Piérola, A; Alonso-Dominguez, JM; Benton, C; Hong, J; Malcovati, L; Mazure, D; Lee, JH; Yeh, SP; Goursaud, L; Barcellini, W; Wu, E; Corzo, D; Kuida, K; Stone, RM.

    Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B-8800 in lower-risk myelodysplastic syndrome

    LEUKEMIA RESEARCH. 2025; 156: [doi:10.1016/j.leukres.2025.107735]

  • Martinez-Picado, J; Kwon, M; Salgado, M.

    The power of ten in HIV remission: insights from hematopoietic stem cell transplantation

    Current Opinion in HIV and AIDS. 2025; 20(5): 456-462 [doi:10.1097/COH.0000000000000954]

  • Cesaro, S; Verheggen, I; Tridello, G; Styczynski, J; Roeven, WHM; Hwang, A; Stamouli, M; Petrov, Y; Ben Abdeljelil, N; Mazilier, P; Zaidman, I; Tambaro, FP; Elias, S; Verna, M; Ricoma, JM; Karas, M; Corral, LL; Goussetis, E; Cerretti, R; Perruccio, K; Hornakova, M; Wölfl, M; Nordlander, A; Biffi, A; Spadea, M; Salinas, AS; Bramanti, S; Belendez, C; Skert, C; Gozdzik, J; Cuoghi, A; Mas, MH; Pennisi, M; de Becker, A; Richardson, D; Peric, Z; de la Camara, R; Averbuch, D.

    A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT

    BONE MARROW TRANSPLANTATION. 2025; : [doi:10.1038/s41409-025-02703-1]

  • Capes, A; Mooyaart, JE; Blaise, D; Bramanti, S; Kwon, M; Mohty, M; Chevallier, P; Vydra, J; Reményi, P; Forcade, E; Corral, LL; Itälä-Remes, M; Bazarbachi, A; Derenzini, E; Hoogenboom, JD; Kuball, J; Battipaglia, G; Malard, F; Ruggeri, A.

    Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation

    BRITISH JOURNAL OF HAEMATOLOGY. 2025; : [doi:10.1111/bjh.70050]

  • Chorafa, E; Iosifidis, E; Oletto, A; Warris, A; Castagnola, E; Bruggemann, R; Groll, AH; Lehrnbecher, T; Antolin, LF; Mesini, A; Alkhaaldi, AA; Baquero-Artigao, F; Cetin, BS; Ebrahimi-Fakhari, D; Emonts, M; Esposito, S; Fainardi, V; Ghimenton-Walters, E; Gijón, M; Guerrero, AG; Grasa, CD; Kairiene, I; Kildonaviciute, K; Kourti, M; Manzanares, A; Mendoza-Palomar, N; Noni, M; Papakonstantinou, E; Paulus, S; Perwein, T; Rascon, J; Rincón-López, E; Soler-Palacin, P; Solopova, G; Spoulou, V; Strenger, V; Tedford, K; Tzika, C; Zsigmond, B; Roilides, E.

    Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2025; 47(6): 222-230 [doi:10.1097/MPH.0000000000003070]

  • Carpio, C; de la Cruz-Vicente, F; García-Sanz, R; Zeberio, I; Barrenetxea, C; Domingo-Domenech, E; Bastos, M; Martinez, AR; Gómez-Prieto, P; Rodriguez, A; Casanova, M; Cladera-Serra, A; Cespedes, JN; Martínez, C; Moreno-Velázquez, M; Garcia-Galea, E; Abrisqueta, P; Bosch, F.

    A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial

    BRITISH JOURNAL OF HAEMATOLOGY. 2025; : [doi:10.1111/bjh.70028]

  • Gomez-Llobell, M; Smith, CS; Gómez-Costas, D; Gómez-Centurión, I; Domínguez, JMG; Escudero-Vilaplana, V; Bullido, YF; Carbonell, D; Pion, M; Bailén, R; Gil-Perotin, S; Ginés, MLM; Revuelta-Herrero, JL; Fernández-Caldas, P; Fernández, VAP; Collado-Borrell, R; Bastos-Oreiro, M; Villanueva-Bueno, C; García-Sanz, R; Kwon, M.

    ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling

    BONE MARROW TRANSPLANTATION. 2025; : [doi:10.1038/s41409-025-02679-y]

  • Marin-Quílez, A; Sánchez-Fuentes, A; Zamora-Cánovas, A; Gómez-González, PL; Diaz-Ajenjo, L; Benito, R; Rodríguez-Alén, A; Sevivas, T; Murciano, T; Murillo, L; Butta, NV; Revilla, N; Campos, R; Escribano, P; Esteve, J; Fernández-Mosteirin, N; Ferrer-Marin, F; Hernández, L; Huerta-Aragonés, J; León, A; López-Duarte, M; López, E; Martín-Salces, M; Nomdedeu, M; Oña, R; Peláez-Pleguezuelos, I; Ramos, F; Sebastián, E; Serrano, C; Sierra-Aisa, C; Vidal-Laso, R; González-Porras, JR; Lozano, ML; Bastida, JM; Rivera, J.

    Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

    BRITISH JOURNAL OF HAEMATOLOGY. 2025; : [doi:10.1111/bjh.70001]

  • Bento, L; Gutiérrez, A; Martinez, C; Verdet, MCO; Sorribes, M; Caballero, AC; Peña, M; Pérez, A; Jiménez-Ubieto, A; Medina, L; Bastos-Oreiro, M; Caldas-González, PF; Navarro, B; Salcedo, I; Abrisqueta, P; Español, I; Cornago, J; Martín-Moro, F; García, L; Gómez, P; Varela, MR; Puente, M; Zanabili, J; Zudaire, T; Zeberio, I; del Campo, R; González, L; González, P; Blázquez, C; Rovira, J; Sitges, M; Franch-Sarto, M; Cabero, A; Mussetti, A; Montoro, J; Sampol, A; Sureda, A; Caballero, D; García-Sancho, AM.

    Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

    Blood Advances. 2025; 9(13): 3281-3292 [doi:10.1182/bloodadvances.2024015415]

  • Pena-Burgos, EM; Duart, MA; Lotto, FA; Bravo-Arribas, C; Martínez-Payo, C; De León-Luis, JA; Suárez-González, J; Pozo-Kreilinger, JJ; Regojo-Zapata, RM.

    Intrauterine-diagnosed fetal intracranial adamantinomatous craniopharyngioma: A case report with histopathological and molecular characterization

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2025; : [doi:10.1002/ijgo.70357]

  • Verdú-Bou, M; Baptista, MJ; Ribeiro, ML; Méndez-López, A; Profitós-Pelejà, N; Frontzek, F; Roué, G; Mate, JL; Pellicer, M; Abrisqueta, P; Castellví, J; Bastos-Oreiro, M; Menárguez, J; Alcoceba, M; González-Barca, E; Climent, F; Salar, A; Sancho, JM; Staiger, AM; Ott, G; Anagnostopoulos, I; Esteller, M; Lenz, G; Tapia, G; Navarro, JT.

    The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential

    Blood Advances. 2025; 9(12): 2953-2967 Nº de citas: 1 [doi:10.1182/bloodadvances.2025016180]

  • Kuter, DJ; Ghanima, W; Cooper, N; Liebman, HA; Zhang, L; Hu, Y; Miyakawa, Y; Homenda, W; Galindo, LEM; Basquiera, AL; Tan, CW; Saydam, G; Huetter-Kroenke, ML; Chai-Adisaksopha, C; Gomez-Almaguer, D; Tran, H; Shin, HJ; Junior, ADD; Lazar, Z; Izquierdo, CP; Kirgner, I; Lucchini, E; Kuzmina, G; Fillitz, M; Audia, S; Taparia, M; Cordoba, M; Diab, R; Yao, MJ; Gouia, I; Lee, MCL; Daak, A.

    Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

    BLOOD. 2025; 145(24): 2914-2926 Nº de citas: 2 [doi:10.1182/blood.2024027336]

  • Bergas, A; de Egea, G; Albasanz-Puig, A; Machado, M; Vinñdo, B; Estévez-Prieto, A; Maluquer, C; Carro, I; Pérez-González, A; Regalado-Artamendi, I; Gómez-Centurión, IA; Laporte-Amargós, J; Sastre-Escolà, E; Badia-Tejero, AM; García, P; Larrosa, N; Muñoz, P; Berbel, D; Ardanuy, C; Carratala, J; Gudiol, C.

    Effectiveness of the BioFire FilmArray for the rapid detection of bloodstream infection in haematological patients with febrile neutropenia (the ONFIRE study): study protocol of a prospective, multicentre observational study at three reference university hospitals in Spain

    BMJ Open. 2025; 15(6): [doi:10.1136/bmjopen-2025-101040]